Articles |
From the First Department of Internal Medicine, Kobe University School of Medicine, Japan.
Correspondence to Mitsuhiro Yokoyama, MD, First Department of Internal Medicine, Kobe University School of Medicine, 7-5-1, Kusunoki-cho, Chuo-ku, Kobe 650, Japan.
Abstract We have previously reported that lysophosphatidylcholine (LPC), which accumulates in oxidized LDL and atherosclerotic arteries, inhibits endothelium-dependent relaxation and modulates Ca2+ regulation in cultured bovine aortic endothelial cells. To test the effect of LPC on endothelium-dependent relaxation and endothelial Ca2+ regulation in intact vessels, we simultaneously measured both isometric tension and endothelial cytosolic free Ca2+ concentration ([Ca2+]i), using fura 2, in intact endothelial cells of aortic strips isolated from rabbits. In the aortic strips precontracted with phenylephrine, cumulative addition of acetylcholine (ACh) dose dependently induced endothelium-dependent relaxation, with an increase in endothelial [Ca2+]i, and positive correlation was obtained between these two parameters. LPC (2 to 20 µmol/L) inhibited both ACh (3 µmol/L)-induced endothelium-dependent relaxation and an increase in endothelial [Ca2+]i in a dose-dependent manner. On the other hand, phosphatidylcholine (20 µmol/L) affected neither ACh-induced endothelium-dependent relaxation nor an increase in endothelial [Ca2+]i. LPC had no effect on endothelium-independent relaxation and a decrease in smooth muscle [Ca2+]i induced by nitroglycerin. Thus, the inhibitory effect of LPC on endothelium-dependent relaxation is due to the inhibition of agonist-induced Ca2+ mobilization in vascular endothelial cells, which is an essential step in the synthesis of endothelium-derived relaxing factor.
Key Words: phospholipids vascular endothelium lysophosphatidylcholine endothelium-derived relaxing factor intracellular calcium
This article has been cited by other articles:
![]() |
D. Mehta Lysophosphatidylcholine: an enigmatic lysolipid Am J Physiol Lung Cell Mol Physiol, August 1, 2005; 289(2): L174 - L175. [Full Text] [PDF] |
||||
![]() |
S. Kawashima and M. Yokoyama Dysfunction of Endothelial Nitric Oxide Synthase and Atherosclerosis Arterioscler. Thromb. Vasc. Biol., June 1, 2004; 24(6): 998 - 1005. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Chaudhuri, S. M. Colles, D. S. Damron, and L. M. Graham Lysophosphatidylcholine Inhibits Endothelial Cell Migration by Increasing Intracellular Calcium and Activating Calpain Arterioscler. Thromb. Vasc. Biol., February 1, 2003; 23(2): 218 - 223. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. M. Colles and G. M. Chisolm Lysophosphatidylcholine-induced cellular injury in cultured fibroblasts involves oxidative events J. Lipid Res., August 1, 2000; 41(8): 1188 - 1198. [Abstract] [Full Text] |
||||
![]() |
Y. Rikitake, S. Kawashima, T. Yamashita, T. Ueyama, S. Ishido, H. Hotta, K.-i. Hirata, and M. Yokoyama Lysophosphatidylcholine Inhibits Endothelial Cell Migration and Proliferation via Inhibition of the Extracellular Signal-Regulated Kinase Pathway Arterioscler. Thromb. Vasc. Biol., April 1, 2000; 20(4): 1006 - 1012. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. M Dart and J. P.F Chin-Dusting Lipids and the endothelium Cardiovasc Res, August 1, 1999; 43(2): 308 - 322. [Abstract] [Full Text] [PDF] |
||||
|
ATVB Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 1997 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |